Advertisement
Advertisement
ACH
Accendra Health, Inc.
0.20
USDSponsored
-0.09
-31.87%
Nov 06, 15:59 UTC -5
Closed
After-Market
0.21
+0.01
+4.87%
Accendra Health, Inc. (ACH) Earnings
ACH Earnings Reports
Positive Surprise Ratio
ACH beat 2 of 5 last estimates.
40%
Next Report
Date of Next Report
Feb 17, 2027
Estimate for Q4 26 (Revenue/ EPS)
$638.42M
/$0.22
Implied change from Q3 26 (Revenue/ EPS)
+6.09%
/-195.65%
Implied change from Q4 25 (Revenue/ EPS)
-9.95%
/+4.76%
Accendra Health, Inc. earnings per share and revenue
On Nov 05, 2026, ACH reported earnings of -0.23 USD per share (EPS) for Q3 26, missing the estimate of -0.01 USD, resulting in a -2177.23% surprise. Revenue reached 601.78 million, compared to an expected 623.55 million, with a -3.49% difference. The market reacted with a -31.87% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.22 USD, with revenue projected to reach 638.42 million USD, implying an decrease of -195.65% EPS, and increase of 6.09% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
BillionToOne, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.14
Actual
$0.32
Surprise
+115.34%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
PERRIGO COMPANY PLC
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.50
Actual
$0.60
Surprise
+18.44%
LeMaitre Vascular, Inc.
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.70
Actual
$0.65
Surprise
-7.14%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.10%
Apyx Medical Corporation Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.04
Surprise
+57.98%
FAQ
What were Accendra Health, Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Accendra Health, Inc. reported EPS of -$0.23, missing estimates by -2177.23%, and revenue of $601.78M, -3.49% below expectations.
How did the market react to Accendra Health, Inc.'s Q3 2026 earnings?
The stock price moved down -31.87%, changed from $0.30 before the earnings release to $0.20 the day after.
When is Accendra Health, Inc. expected to report next?
The next earning report is scheduled for Feb 17, 2027.
What are the forecasts for Accendra Health, Inc.'s next earnings report?
Based on --
analysts, Accendra Health, Inc. is expected to report EPS of $0.22 and revenue of $638.42M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.